Constellium (CSTM)
NYSE:CSTM
Top Page
Constellium
(NYSE:CSTM)
Select Model
Select Model
Rating:64Neutral
Price Target:
$31.00
▲(5.19% Upside)
Action:ReiteratedDate:03/13/26
The score is anchored by mid-range financial strength due to still-elevated leverage and uneven revenue/FCF consistency. Offsetting this, the earnings call guidance and commentary point to continued solid EBITDA/FCF generation and improving leverage, technicals show a generally supportive uptrend, and valuation appears attractive on a low P/E.
Positive Factors
Consistent operating cash flow
Constellium’s consistently positive operating cash flow provides a durable funding base for capex, debt reduction and shareholder returns. Over the next 2–6 months steady OCF reduces refinancing risk and underpins the company’s ability to execute Vision 2028 investments and measured buybacks.
Negative Factors
Elevated leverage remains a constraint
Despite improvement, still‑elevated leverage limits financial flexibility and raises sensitivity to margin or cash‑flow shocks. High debt relative to equity constrains the pace of deleveraging, increases interest exposure and makes capital allocation reliant on consistent FCF generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent operating cash flow
Constellium’s consistently positive operating cash flow provides a durable funding base for capex, debt reduction and shareholder returns. Over the next 2–6 months steady OCF reduces refinancing risk and underpins the company’s ability to execute Vision 2028 investments and measured buybacks.
Read all positive factors
Constellium (CSTM) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.98B
Dividend YieldN/A
Average Volume (3M)2.42M
Price to Earnings (P/E)9.6
Beta (1Y)1.25
Revenue Growth8.48%
EPS Growth12.10%
CountryUS
Employees12,000
SectorBasic Materials
Sector Strength58
IndustryAluminum
Share Statistics
EPS (TTM)0.71
Shares Outstanding135,069,780
10 Day Avg. Volume2,340,582
30 Day Avg. Volume2,420,856
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.77
Price to Sales (P/S)0.31
P/FCF Ratio16.56
Enterprise Value/Market Cap1.48
Enterprise Value/Revenue0.80
Enterprise Value/Gross Profit8.32
Enterprise Value/Ebitda8.24
Forecast
1Y Price Target
$29.75Price Target Upside0.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)2.01
Revenue Forecast (FY)$9.59B
Constellium Business Overview & Revenue Model
Company Description
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the packaging, aerospace, and automotive end-markets. The company operates through three segments: ...
How the Company Makes Money
Constellium primarily makes money by manufacturing and selling aluminum products—mainly rolled products and extruded solutions—to industrial customers in its served end markets (notably packaging, automotive/transportation, and aerospace/defense)....
Constellium Earnings Call Summary
Earnings Call Date:Feb 18, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call communicated materially improved operating performance, record and near-record profitability, stronger free cash flow and aggressive shareholder returns, underpinned by segment-level recoveries (notably PARP and A&T) and improved recycling economics. Management balanced these positives with caution about the cyclicality and volatility of scrap/metal economics, regional automotive weakness (especially in Europe), inflationary cost pressure, and some lingering operational/corporate cost headwinds. Guidance for 2026 is constructive but includes assumptions about the persistence of favorable scrap spreads and demand trends, and management launched Vision 2028 to institutionalize further efficiencies.Positive Updates
Strong Quarterly Shipments and Revenue Growth
Q4 shipments of 365,000 tons, up 11% year-over-year; Q4 revenue of $2.2 billion, up 28% year-over-year driven by higher shipments and higher revenue per ton (including higher metal prices).
Negative Updates
Missed Ambitious Safety Target
Although safety improved, the company missed its target of a 1.5 recordable case rate, finishing 2025 at 1.9 and emphasizing continued focus is needed.
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Quarterly Shipments and Revenue Growth
Q4 shipments of 365,000 tons, up 11% year-over-year; Q4 revenue of $2.2 billion, up 28% year-over-year driven by higher shipments and higher revenue per ton (including higher metal prices).
Read all positive updates
Company Guidance
Constellium guided 2026 adjusted EBITDA excluding the non‑cash metal‑price‑lag impact to $780–$820 million and free cash flow in excess of $200 million, with expected CapEx of ~ $115 million (≈ $100 million return‑seeking), cash interest of ~ $125 million, cash taxes of ~ $70 million and working capital a use of cash; they expect leverage to trend lower from year‑end 2025 (net debt $1.8 billion, leverage 2.5x, liquidity $866 million), have ~ $106 million remaining on the buyback, and no bond maturities until 2028. For context, FY‑2025 shipments were 1.5 million tons (+4%), revenue $8.4 billion (+15%), net income $275 million, adjusted EBITDA $846 million (incl. $126 million metal price lag; ex‑lag $720 million), free cash flow $178 million, and Q4‑2025 shipments were 365k tons, revenue $2.2 billion, adj. EBITDA $280 million (incl. $67 million lag; ex‑lag $213 million) with Q4 free cash flow $110 million. They reiterated longer‑term targets of adjusted EBITDA ex‑lag $900 million and free cash flow $300 million by 2028 and raised the A&T adjusted‑EBITDA per ton target to $1,300 (from $1,100).Constellium Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
52
Neutral
Cash Flow
55
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.45B | 7.33B | 7.24B | 8.53B | 6.15B |
| Gross Profit | 856.74M | 938.00M | 710.00M | 963.00M | 664.00M |
| EBITDA | 846.74M | 542.00M | 605.00M | 539.00M | 764.00M |
| Net Income | 272.92M | 56.00M | 125.00M | 308.00M | 257.00M |
Balance Sheet | |||||
| Total Assets | 5.35B | 4.73B | 4.66B | 5.27B | 5.26B |
| Cash, Cash Equivalents and Short-Term Investments | 119.96M | 141.00M | 210.00M | 177.16M | 167.17M |
| Total Debt | 1.94B | 1.94B | 1.87B | 2.19B | 2.42B |
| Total Liabilities | 4.38B | 4.01B | 3.80B | 4.47B | 4.93B |
| Stockholders Equity | 951.71M | 706.00M | 843.00M | 780.16M | 311.59M |
Cash Flow | |||||
| Free Cash Flow | 158.95M | -112.00M | 66.00M | 186.02M | 125.00M |
| Operating Cash Flow | 488.85M | 301.00M | 432.00M | 472.94M | 357.00M |
| Investing Cash Flow | -315.90M | -318.00M | -219.00M | -285.87M | -221.00M |
| Financing Cash Flow | -207.94M | -56.00M | -174.00M | -168.16M | -435.00M |
Constellium Technical Analysis
Positive
29.47
Price Trends
25.03
Positive
21.93
Positive
18.32
Positive
Market Momentum
1.00
Negative
66.77
Neutral
88.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CSTM, the sentiment is Positive. The current price of 29.47 is above the 20-day moving average (MA) of 25.38, above the 50-day MA of 25.03, and above the 200-day MA of 18.32, indicating a bullish trend. The MACD of 1.00 indicates Negative momentum. The RSI at 66.77 is Neutral, neither overbought nor oversold. The STOCH value of 88.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CSTM.
Constellium Risk Analysis
Constellium disclosed 11 risk factors in its most recent earnings report. Constellium reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
material way, which in turn can affect the price of the Company's publicly traded securities. Q4, 2025
2.
It is not possible to predict or identify all the risks and uncertainties to the Company's business and the following is not Q4, 2025
3.
Report. Q4, 2025
Constellium Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $19.33B | 16.99 | 18.80% | 0.75% | 20.08% | ― | |
67 Neutral | $3.39B | 34.48 | 8.14% | 0.43% | 3.93% | -73.94% | |
65 Neutral | $6.63B | 88.30 | 5.54% | ― | 20.15% | -72.89% | |
65 Neutral | $2.31B | 16.50 | 14.22% | 2.64% | 7.69% | 91.86% | |
64 Neutral | $3.98B | 9.65 | 29.48% | ― | 8.48% | 12.10% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | $2.65B | -12.82 | -127.78% | ― | -13.39% | 88.25% |
* Basic Materials Sector Average
CSTM
Constellium
29.64
21.58
267.74%
AA
Alcoa
73.03
48.56
198.39%
MTRN
Materion
163.34
85.52
109.90%
CENX
Century Aluminum
66.96
51.36
329.23%
KALU
Kaiser Aluminum
142.67
89.10
166.32%
NGVT
Ingevity
75.25
43.29
135.45%
Constellium Corporate Events
Business Operations and StrategyStock Buyback
Constellium Launches New $300 Million Share Repurchase Program
Positive
Mar 12, 2026
On March 12, 2026, Constellium announced that its Board of Directors authorized a new share repurchase program of up to $300 million of outstanding ordinary shares, effective after the May 21, 2026 Annual General Meeting and running through Decemb...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.